The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2405090.pdf
Reference42 articles.
1. Armitage JO . Bone marrow transplantation. N Engl J Med 1994; 330: 827–838.
2. Yeager AM . Allogeneic hematopoietic cell transplantation in inborn metabolic diseases. Ann Hematol 2002; 81: S16–S19.
3. Burt RK, Traynor AE, Craig R, Marmont AM . The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003; 31: 521–524.
4. Wingard JR, Vogelsang GB, Deeg HJ . Stem cell transplantation: supportive care and long-term complications. Hematology 2002, 422–444.
5. Tabbara IA, Zimmerman K, Morgan C, Nahleh Z . Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 2002; 162: 1558–1566.
Cited by 325 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular Prospective on Malignant Transformation of Mesenchymal Stem Cells: An Issue in Cell Therapy;Cellular Reprogramming;2024-06-01
2. Human amniotic epithelial stem cell is a cell therapy candidate for preventing acute graft-versus-host disease;Acta Pharmacologica Sinica;2024-05-27
3. Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience;Frontiers in Pediatrics;2024-05-09
4. International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges;Cytotherapy;2024-05
5. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial;BMC Medicine;2024-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3